Ticker Tape Digest

Tuesday - July 6, 2021

By Leo Fasciocco -- TTD

   Ticker Tape Digest presents its daily stock market report containing stocks to go long as Breakout Trades, Quick Trades, or Bargain Accumulation Trades.

  We also feature stocks under Significant Accumulation that are poised to breakout.

   The TTD report also contains stocks to short as  breakdown plays and as bargain (swing trade) shorts.

  Investors should  tend to try to go with a strategy that fits with the stock market's trend, unless there is a special situation play.

  TTD's Breakout Stocks - Long are most suitable for aggressive investors seeking ideal entry points into leading stocks, especially during bull markets. They can do extremely well in bull markets with gains of as much as several hundred percent.

 These stocks can also do extremely well during strong market rallies, or if they are in a industry group that is performing very well. They tend to have strong earnings outlooks and are near new-52 week, or all-time highs.

  TTD Swng - Quick Trade Stocks - Long These are leading issues that have pulled back in recent days, but could move higher soon. They are most suitable for Aggressive Investors willing to trade short term. These stocks will do extremely well during market advances. They have about 74% win rate. During market rally sequences the win rate is even higher. The return is small 3% to 8% in just a few days.

   TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks will do very well during bear markets or market pull backs.

  TTD's Bearish breakdown stocks to sell short. These issues have potential to fall sharply. They often show a technical breakdown and also some fundamental business problem such as weak earnings.  

 TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).

 TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out. A good idea is to study the list and be ready to move into a stock quickly as it hits its breakpoint.

TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the breakpoint. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.

It is also essential to have a stop loss strategy for all stocks in which positions are taken. Not every stock will work as expected. It is important for investors to "police" their portfolios and avoid getting trapped in any bad positions.

 Quality rating of breakout  Two key factors: 1 - Stock near all-time high in price or near a 52-week high. 2 - earnings growth current year is strong. The ideal play is a stock with an Above Average Quality Rating. The stock is near a new high and will have strong earnings. TTD's other ratings are Average and Below Average.

   TTD also has  special feature sections on  Educational Tips on Investing.

   To email Mr. Leo Fasciocco  leo@tickertapedigest.com.   

   For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-878-8381 or 480-704-3331.

Tuesday - July 6, 2021

TTD's Breakout Stocks

  Stock Market Overview

Total Buy Breakouts   -  9

Quality of Breakouts -  Average

Stocks Screened - 12,234

Bull side -  Large list of breakouts with some good looking plays.

Stock market  -  Major averages hold bullish in all time zones.

Comment -  Bulls can be venturesome. Earnings will be coming in a few weeks. Look for any pre-announcements.

See Latest Earnings Reports -  A company that tops the Street's highest earnings estimate has potential to go higher. Key earnings beats -  None.

Stock Market Momentum

(Daily is based on a moving average)

Ticker Tape Digest's

Timely Breakout Stocks From Tape Action

(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work.

They are ranked according to percentage change and classified as leaders or other.

(Trading strategy: One should buy breakout stocks near breakpoint by using market order or stop buy.  They can also be bought soon after a follow through move, sometimes on an intraday pullback. )  

Today's Featured TTD Breakout Stock

Syneos Health Inc. (SYNH) - 91.15, up 1.65 - Breakpoint 89.91

Net To Climb 26% This Year, TTD Targets 110

     SYNH, based in Morrisville, N.C., is a biotech service firm. Annual revenues: $4.4 billion. SYNH's stock moves higher Tuesday and breaks out from its 12-week flat base.

  So far today, SYNH is trading 849,746 shares. Its average daily volume is 1.1 million shares.

  TTD sees potential for more on the upside.

  SYNH is a leader. The stock has climbed from $30 back in 2020 to as high as $91 now. .

  Tuesday, SYNH's rose in the morning and worked higher.

  Around noon, the stock cut across its breakpoint line.

  STNH then continued higher and closed near its high for the day. That is bullish.

 The stock was unchanged in after-hours trading.  

  Tape Action

  SYNH's tape action shows the recent block trades.

  One can see the price for the blocks climbing from $89.08 in the morning  to as high as $91.16 late in the day.

  A key bullish trade came in the morning when a block of 40,605 shares crossed the tape at $89.50.

  That was up from the prior block at $89.08 on 2,000 shares.

  Near the close a big block of 190,925 shares crossed at $91.15.

That was down from the prior big block at $91.16 on 2,000 shares.

    Business

 SYNH provides biopharmaceutical product development solutions through its contract research organization.

 The service ranges from  contract commercial organization ranging from  early phase (Phase I) clinical trials to the full commercialization of products.

 It brings together some 24,000 clinical and commercial professionals with the ability to support customers in some 110 countries.

Together it shares insights, leverages latest technologies and apply advanced business practices to deliver important therapies to patients.

   Charts 

  SYNH's 12-month performance chart shows the stock up 55% versus a 35% gain for the stock market.

  Insiders were recent buyers at $40 to $42 using stock options.

  They were sellers at $76 to $90 a share.

  SYNH's long-term chart shows the stock coming public at $24.62 in late 2014.

  The stock advanced to $72 by early 2020.  However, the stock fell to $30 in early 2020 when the stock market tumbled

  Since then, the stock surged to a peak at $91.32.

  SYNH formed a flat base with two shake outs to the downside.

  The stock now breaks out with a good widening of the daily spread.

  The move to a new all-time high is bullish.

  The stock's CCI momentum indicator is  bullish.

  Earnings Outlook

  This year, the Street predicts a 26% leap in net to $4.31 a share versus $3.41 the prior year.

  The stock has a price-earnings ratio of 21.

  Looking out to 2022. the Street predicts a 15% rise in net to $4.97 a share from the anticipated $4.31 this year.

  Profits for the second quarter should jump 62% to 94 cents a share from the 58 cents the previous year.

  The highest estimate is at 97 cents a share. The company beat the Street estimate three out of the past four quarter and matched it once.

  Net for the third quarter should climb 17% to $1.22 a share from the $1.04 the prior year.

Strategy Opinion:   TTD is targeting SYNH for a move to $110.  A protective stop can be placed near $86.

Intermediate-Term Rating:  Average.

Suitability:  Average Bulls.  

                                   TTD's special research of Stock's Prior Performance:  

           Stock's Prior Performance After A Breakout

(In actual trading, entry and exit points could vary depending on broker execution.

Also, ideal are breakouts to a new 52-week high or better, perhaps all-time highs.)

  Stock's Long-term Chart

   Stock's Price Performance after Reporting Earnings

 Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  -  Insider Selling in Red

Charts of Selected Breakout Stocks

Ticker Tape Digest’s

Stocks To “Sell or Short”

    Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.

Shorts from tape action  -  5

Stocks Screened - 12,234

Long-Term Environment for bears: Unfavorable.

Bear Side -  Small list of shorts, but some interesting plays for aggressive bears.

List of Stocks To Sell or Short

TTD’s Feature Bear Play

Provention Bio Inc. (PRVB) - 6.11

Loss Seen This Year and Next, TTD Sees Drop to 4.80

  PRVB, based in Red Bank, N.J., is a biotech firm working on treatment sof immunemedicated diseases. Annual revenues: Nil. PRVB's stock falls sharply Tuesday and undercuts technical support.

  So far today PRVB is trading a heavy 9 million shares, five times its average daily volume of 1.8 million shares.

  The drop was due in part to a shareholde law suit.

  TTD sees potential for more on the downside.

  PRVB's stock fell in the morning and undercut key technical support.

  The stock touched an intraday low of $5.73 around midday.

  The stock then lifted slightly and trended sideways the rest of the day.

  In after-hours trading PRVB was up 4 cents a share.

  Tape Action

  PRVB's tape action shows the recent block trades.

  One can see the price for the blocks falling from $8.30 in the prior session down to $5.85 in the morning.

  A key bearisht rade came in the morning when a block of 120,456 shares (duplicated) crossed at $6.40.

  That was down from the prior block at $6.65 on 13,665 shares.

   Business

 PRVB develops therapeutics targeting immune-mediated diseases.

 The company is working on treatments for  type one diabetes , Crohn’s disease, ulcerative colitis, lupus and other viral diseases.

PRVB’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031.

 Earnings:

  This year, PRVB is expected to show a loss of $2.36 a share compared with a loss of $1.88 the prior year.

  Looking out to 2022, the Street predicts a loss of $1.79 a share fro 2022.

  For the upcoming second quarter, a loss of 51 cents a share is expected comapred with a loss of 46 cents the prior year.

Charts:  

  PRVB's daily chart shows the stock trending lower from $15 earlier this year down to $6.36 by April. The stock tried to form a bottom, but now gaps lower.

Strategy Opinion: TTD  is targeting PRVB for a decline to $4.80 within the next few months, or sooner. A protective stop buy can be placed near $6.50.

Suitability:  Aggressive Bears.

  TTD's Stock Probability research of Prior Performance:  

   Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  - Insider Selling in Red

   TTD takes no responsibility for trading by those using this information. The stocks presented in our report are those we deem the best looking "Day Trades" for the long side. We take no responsibility for the accuracy of this data, although every effort is made to present the information correctly. Copyright Ticker Tape Digest. - 2021

    TTD columnist Leo Fasciocco has covered the stock market for over 30 years. His articles appear in many publications. He has also been  a speaker at the Money Show conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”

   For information to subscribe to the Ticker Tape Digest Services call: Beverly Owen at 1-480-704-3331.

   Distributed by Corona Publishing Enterprises. TickerTape Digest Inc. 1220 W. Sherri, Gilbert, Az. 85233.

  TTD “Professional Report” is available on the Web: $100 per month. Password needed. Published daily - around 20 times a month.  

 TTD Pro Report includes a Morning chart slide show of breakout stocks, a Midsession video-audio show with commentary on breakout stocks and shorts and a Final end of day overall report on breakout stocks for the session, short plays and accumulation plays.  There are other features too such as Quick Trades and Long-term Plays.  

TTD Daily Report is $39. It covers a Morning slide show of charts of stocks breaking out and a TTD end of day print report covering breakout stocks and shorts.

 Credit cards accepted. Payable to Corona Publishing Enterprises.

(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission.)